Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Insulet Corporation stock | $298.69

Learn how to easily invest in Insulet Corporation stock.

Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD) are listed on the NASDAQ and all prices are listed in US Dollars. Insulet Corporation employs 1,900 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Insulet Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PODD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Insulet Corporation stock price (NASDAQ: PODD)

Use our graph to track the performance of PODD stocks over time.

Insulet Corporation shares at a glance

Information last updated 2021-10-17.
Latest market close$298.69
52-week range$214.93 - $309.99
50-day moving average $293.15
200-day moving average $279.72
Wall St. target price$291.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.47

Buy Insulet Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Insulet Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Insulet Corporation price performance over time

Historical closes compared with the close of $298.69 from 2021-10-20

1 week (2021-10-15) -0.60%
1 month (2021-09-22) 3.71%
3 months (2021-07-22) 10.03%
6 months (2021-04-22) 5.31%
1 year (2020-10-21) 23.87%
2 years (2019-10-21) 94.11%
3 years (2018-10-19) 238.69%
5 years (2016-10-21) 645.23%

Is Insulet Corporation under- or over-valued?

Valuing Insulet Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Insulet Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Insulet Corporation's PEG ratio

Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9469. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Insulet Corporation's EBITDA

Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $123.7 million.

The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.

Insulet Corporation financials

Revenue TTM $995.6 million
Operating margin TTM 5.94%
Gross profit TTM $582.3 million
Return on assets TTM 2.08%
Return on equity TTM -5.97%
Profit margin -3.06%
Book value $6.69
Market capitalisation $20.7 billion

TTM: trailing 12 months

Shorting Insulet Corporation shares

There are currently 2.4 million Insulet Corporation shares held short by investors – that's known as Insulet Corporation's "short interest". This figure is 13% up from 2.1 million last month.

There are a few different ways that this level of interest in shorting Insulet Corporation shares can be evaluated.

Insulet Corporation's "short interest ratio" (SIR)

Insulet Corporation's "short interest ratio" (SIR) is the quantity of Insulet Corporation shares currently shorted divided by the average quantity of Insulet Corporation shares traded daily (recently around 292594.7761194). Insulet Corporation's SIR currently stands at 8.04. In other words for every 100,000 Insulet Corporation shares traded daily on the market, roughly 8040 shares are currently held short.

However Insulet Corporation's short interest can also be evaluated against the total number of Insulet Corporation shares, or, against the total number of tradable Insulet Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Insulet Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Insulet Corporation shares in existence, roughly 30 shares are currently held short) or 0.0343% of the tradable shares (for every 100,000 tradable Insulet Corporation shares, roughly 34 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Insulet Corporation.

Find out more about how you can short Insulet Corporation stock.

Insulet Corporation share dividends

We're not expecting Insulet Corporation to pay a dividend over the next 12 months.

Insulet Corporation share price volatility

Over the last 12 months, Insulet Corporation's shares have ranged in value from as little as $214.93 up to $309.99. A popular way to gauge a stock's volatility is its "beta".

PODD.US volatility(beta: 0.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 0.6799. This would suggest that Insulet Corporation's shares are less volatile than average (for this exchange).

Insulet Corporation overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts. .

Frequently asked questions

What percentage of Insulet Corporation is owned by insiders or institutions?
Currently 0.404% of Insulet Corporation shares are held by insiders and 102.829% by institutions.
How many people work for Insulet Corporation?
Latest data suggests 1,900 work at Insulet Corporation.
When does the fiscal year end for Insulet Corporation?
Insulet Corporation's fiscal year ends in December.
Where is Insulet Corporation based?
Insulet Corporation's address is: 100 Nagog Park, Acton, MA, United States, 01720
What is Insulet Corporation's ISIN number?
Insulet Corporation's international securities identification number is: US45784P1012
What is Insulet Corporation's CUSIP number?
Insulet Corporation's Committee on Uniform Securities Identification Procedures number is: 45784P101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site